News roundup
More frequent screening would improve detection of colon cancer
Scott Gottlieb New York
Examining the colon more frequently than is currently recommended may improve
detection and prevention of cancer, according to the preliminary results of a
large study.
The prostate, lung, colorectal, and ovarian cancer screening trial is a
randomised controlled, community based study that is evaluating the effect of
cancer screening on mortality from site specific cancers. Sponsored by the US
National Cancer Institute, the trial is being conducted in 10 screening centres
in the United States.
Between 1993 and 2001 the trial enrolled more than 154000 people aged 55 to
74 years. They will be followed until 2013. The patients were randomly assigned
to receive different tests, including flexible sigmoidoscopy.
The preliminary report gives the findings on patients who underwent flexible
sigmoidoscopy at baseline and at three years (following the trials protocol)
and were referred to their personal doctors for further evaluation of any
abnormalities detected by the screening (JAMA 2003;290:41-8). A polypoid
lesion or mass found by the examiner was considered a positive result of
screening.
About 11500 patients who had flexible sigmoidoscopy and were found to be free
of polyps and cancer were told to come back in three years time for another
examination. Eighty per cent of the patients, or 9317, returned. Of these, 1292
(14%) had abnormal growths, and 292 were found to have cancer. The total
incidence of adenoma or cancer in the distal colon three years after a negative
result of flexible sigmoidoscopy was 3.1%.
A quarter of the patients with adenomas had advanced adenomas, and six distal
colon cancers were detected, giving an incidence of advanced distal lesions of
0.8%. Although it cannot be determined whether these lesions were missed at the
initial screening or whether they developed over the three year observation
period, 81% of patients with advanced distal adenomas had lesions in a portion
of the colon that had been adequately examined at the initial sigmoidoscopy.
The finding is important, because even patients who were carefully examined
at the first screening had polyps or even cancer within three years. Currently,
most patients are told to have flexible sigmoidoscopy once at the age of 50 and
then every five years if nothing is found (Gastroenterology
2003;124:544-60). For colonoscopy the recommendation is once every 10 years if
the first examination is negative (Gastroenterology 1996;111:1178-81).
"The findings at three years, although modest, indicate that more frequent
screening for colon cancer, by detecting precancerous growths, could have an
impact on mortality from this disease," said Dr Robert Schoen, lead author of
the study and an associate professor of medicine and epidemiology at the
University of Pittsburgh School of Medicine.
Dr Schoen said patients should not necessarily think that a negative result
is a permanent clean bill of health. "If you had a colonoscopy last year, I
think at five years you might want to check in with your physician and see if
theres anything new thats been learned [about colon cancer screening]," he
said.
Return to
Vaccination News Home
Page
__»
Right-click to
"open in new window"
DISCLAIMER:
All information, data, and material contained, presented, or provided here
is for general information purposes only and is not to be construed as
reflecting the knowledge or opinions of the publisher, and is not to be
construed or intended as providing medical or legal advice. The decision
whether or not to vaccinate is an important and complex issue and should
be made by you, and you alone, in consultation with your health care
provider.